Tibial nerve - PDFSEARCH.IO - Document Search Engine

Tibial nerve
Results: 57

#	Item
31	PRESS RELEASE For immediate release MIRABEGRON RECEIVES POSITIVE CHMP OPINION FOR TREATMENT OF OVERACTIVE BLADDER SYMPTOMS Chertsey, UK, 19th October[removed]ASTELLAS PHARMA EUROPE Ltd. announced today that the Committee f Add to Reading List Source URL: www.astellas.com Language: English - Date: 2012-10-21 18:34:10 Astellas Pharma Tolterodine Benign prostatic hyperplasia Urination Urinary retention Prostate cancer Percutaneous tibial nerve stimulation Medicine Muscarinic antagonists Overactive bladder
32	Small Joint Series Technique Guide Endoscopic Plantar Fascia Release Using the Smith & Nephew ECTRA™ II Add to Reading List Source URL: www.smith-nephew.com Language: English - Date: 2012-10-29 15:51:44 Plantar fascia Plantar nerve Medial plantar nerve Fasciotomy Flexor digitorum brevis muscle Tibial nerve Human anatomy Anatomy Foot
33	Advisory Committee Briefing Document Add to Reading List Source URL: www.fda.gov Language: English Tolterodine Chemistry Overactive bladder Organochlorides Organic chemistry Amines Percutaneous tibial nerve stimulation Muscarinic antagonists Phenols Pfizer
34	Summary of Safety and Efficacy as Basis for AC Committee Briefing Book Add to Reading List Source URL: www.fda.gov Language: English Clinical research Pharmacology Organochlorides Amines Experimental psychology Placebo Clinical trial Tapentadol Percutaneous tibial nerve stimulation Chemistry Medicine Organic chemistry
35	MYRBETRIQ™ (mirabegron), Overactive Bladder Treatment from Astellas, Now Available Through U.S. Pharmacies NORTHBROOK, Ill., Oct. 22, 2012 – Astellas Pharma US, Inc. (“Astellas”), a U.S. subsidiary of Tokyobased Add to Reading List Source URL: www.simonfoundation.org Language: English - Date: 2012-10-23 22:18:12 Overactive bladder Urodynamic testing Urinary incontinence Urinary retention Astellas Pharma Urinary bladder National Association For Continence Frequent urination Percutaneous tibial nerve stimulation Medicine Urology Incontinence
36	Letter to the Editor Eur Neurol 2012;68:75–78 DOI: [removed] Received: January 2, 2012 Accepted: April 2, 2012 Add to Reading List Source URL: amdapompe.ehclients.com Language: English - Date: 2013-05-26 18:43:36 Urinary incontinence Fecal incontinence Glycogen storage disease type II Pelvic floor Percutaneous tibial nerve stimulation Health Medicine Anatomy
37	JAHC Preview: Frequent Urinary Urgency Join us at the conference and expand your skills for your clients! Urinary Urgency: What is it? Add to Reading List Source URL: www.wholehealthnow.com Language: English - Date: 2013-04-01 10:31:02 Overactive bladder Homeopathy Urinary urgency Urinary bladder Percutaneous tibial nerve stimulation Medicine Anatomy Urology
38	DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration[removed]New Hampshire Avenue Building 66 Add to Reading List Source URL: www.fda.gov Language: English Incontinence Percutaneous tibial nerve stimulation Urinary incontinence Medicine Fecal incontinence Health
39	Remarkable Results. Reduced Risk. » Office-based neuromodulation for overactive bladder » Up to 80% patient response » Significant, sustainable improvements » No serious side-effects Add to Reading List Source URL: www.uroplasty.com Language: English - Date: 2013-10-04 15:01:15 Overactive bladder Neurotechnology Sacral nerve stimulation Incontinence Urge incontinence Tolterodine Solifenacin Medicine Percutaneous tibial nerve stimulation Muscarinic antagonists
40	Microsoft Word - Revised PAS Proposal 2010-Oct.doc Add to Reading List Source URL: www.fda.gov Language: English Clinical research Pharmacology Design of experiments Medical statistics Pharmaceutical industry Clinical trial Food and Drug Administration Percutaneous tibial nerve stimulation Phases of clinical research Medicine Research Health

UPDATE